StrideBio
StrideBio describes itself as a company focused on developing gene therapies. Public site content highlights a therapeutic pipeline, an AAV capsid platform, and AAV vector manufacturing, and states an objective to advance drug development and translate scientific research into treatments.
Industries
Biopharma
Biotechnology
Health Care
Information Technology
Therapeutics
Biotechnology Research
Nr. of Employees
medium (51-250)
Products
Therapeutic pipeline (gene therapy programs)
Collection of gene therapy development programs at various stages of research and development.
Capsid engineering platform
Platform for engineering AAV capsids intended to improve delivery characteristics of gene therapy vectors.
Therapeutic pipeline (gene therapy programs)
Collection of gene therapy development programs at various stages of research and development.
Capsid engineering platform
Platform for engineering AAV capsids intended to improve delivery characteristics of gene therapy vectors.
Services
In-house production capabilities for AAV vectors to support therapeutic programs.
In-house production capabilities for AAV vectors to support therapeutic programs.
Expertise Areas
- Gene therapy development
- AAV vector manufacturing
- Capsid engineering
- Translational drug development
Key Technologies
- Adeno-associated virus (AAV) vectors
- Capsid engineering
- Gene therapy platforms
- Vector manufacturing processes